Alimera Sciences Announces First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Cowen Downgrades Alimera Sciences (ALIM) to Market Perform
May 6, 2016 6:47 AM EDTCowen downgraded Alimera Sciences (NASDAQ: ALIM) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Alimera Sciences click here. For more ratings news on Alimera Sciences click here.
Shares of Alimera Sciences closed at $1.92 yesterday.
... MoreAlimera Sciences (ALIM) Misses Q1 EPS by 4c
May 4, 2016 5:15 PM EDTAlimera Sciences (NASDAQ: ALIM) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.83 million.
"In the U.S. we were pleased to see a record month for... More
